Photo of Chengbo Zeng
Chengbo Zeng, MSc
Research Fellow in Global Health and Social Medicine

Mr. Zeng was selected in a national search for the Postdoctoral Fellowship in Multidrug-Resistant Tuberculosis Epidemiology. He works with a team of epidemiologists and clinicians aiming to improve access to high-quality evidence-based care for multidrug-resistant tuberculosis (MDR-TB) around the world. Mr. Zeng focuses on the endTB observational study. Comprised of over 2,600 patients in 17 countries, this is the largest multi-country study of patients receiving MDR-TB treatment with the newer drugs, bedaquiline and delamanid. He will apply advanced epidemiologic methods (e.g., marginal structural models, gestimation) to longitudinal data to answer pressing outstanding questions related to the safety and effectiveness of different MDR-TB regimens. Under this NIH-funded initiative, he will also contribute to the implementation of a prospective cohort study of patients receiving a shortened, all-oral MDR-TB regimen in one of five countries. Additionally, Mr. Zeng will be the lead author on publications arising from this work and to communicate findings in oral presentations at national and international conferences. Dr. Molly Franke, Associate Professor of Global Health and Social Medicine is his supervisor and mentor.